Theriva Biologics Overview
Theriva Biologics Discounted Cash Flow
DCF Analysis for SYN.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.57
Current Fair Value
$1.57
↑ 54.2% Upside
Undervalued by 54.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison